Short-term outcomes of COVID-19 and risk factors for progression

With a median (IQR) follow-up time of 24.0 (17.5–30.0) days, progression occurred in 19.6% moderate, 27.8% severe and 66.7% critical COVID-19. Neutrophil-to-lymphocyte ratio ≥2.973, age ≥50 years, male sex and comorbidity were associated with progression. https://bit.ly/3crsJr0

Detalles Bibliográficos
Autores principales: Long, Li, Zeng, Xiansheng, Zhang, Xu, Xiao, Wei, Guo, E, Zhan, Wenzhi, Yang, Xuejiao, Li, Chunyan, Wu, Caiyun, Xu, Tingting, Zhan, Chen, Chen, Yuehan, Jiang, Mei, Zhong, Nanshan, Lai, Kefang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173674/
https://www.ncbi.nlm.nih.gov/pubmed/32312863
http://dx.doi.org/10.1183/13993003.00990-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173674/
https://www.ncbi.nlm.nih.gov/pubmed/32312863
http://dx.doi.org/10.1183/13993003.00990-2020

Ejemplares similares